… with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose
anticoagulation may improve outcomes in noncritically ill patients who are hospitalized with …

… interest in the use of therapeutic-dose anticoagulation in patients with COVID-19. We have
… therapeutic-dose anticoagulation with mortality among hospitalized patients with COVID-19. …

… Thrombosis may contribute to morbidity and mortality in Covid-19. We hypothesized that
therapeutic anticoagulation would improve outcomes in critically ill patients with Covid-19. …

… early empirical use of therapeutic anticoagulation in critically ill patients with COVID-19. These
… randomized clinical trials of therapeutic anticoagulation in critically ill patients with COVID-…

… anticoagulation for thromboprophylaxis, a high rate of venous thromboembolism was still
observed among COVID-19 … the use of therapeutic anticoagulation among COVID-19 patients …

… sepsis, anticoagulation plays a key role in the treatment of COVID-19, … for COVID-19-coagulopathy
(CIC Scoring) and stratification of patients for the purpose of anticoagulation therapy …

… of anticoagulant therapy. The ACTION study 4 demonstrated that hospitalized patients with
COVID-19 who received therapeutic anticoagulation … with prophylactic anticoagulation with …

… We believe that these findings suggest that the initiation of therapeutic anticoagulation for
critically ill patients with COVID-19 who require mechanical ventilation is a beneficial …

… among hospitalized patients with coronavirus disease-2019 (COVID-19) and are major …
with COVID-19 [5, 6] Lastly, despite the administration of prophylactic-dose anticoagulation with …

… study of 449 patients with severe COVID-19 [6]. The study found that … It is further suggested
that anticoagulant therapy reduces … therapeutic anticoagulation in cases of severe COVID-19. …